WADE WARREN
No ORCID on file
· 16 papers in corpus
· active 2009-2012
Frequent coauthors
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2012
Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 4-{ 5-Chloro-4-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-[(2-methoxy-6-methyl-phenyl)-methyl-carb…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…